Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on May 16, 2025, recommended Final Dividend of 4.50 per equity share.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 1.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) approved audited financial results for FY24-25 and recommended a final dividend of Rs. 4.50 per share (45%), unchanged from the previous year. Revenue from operations grew to Rs. 1,356.36 crore from Rs. 1,244.70 crore, up about 9% year-on-year. Profit after tax rose to Rs. 160.99 crore from Rs. 123.96 crore, a growth of nearly 30%, while EPS improved to Rs. 17.56 from Rs. 13.52. Statutory auditors S.N. Dhawan & Co LLP issued an unmodified (clean) opinion on the results. The company also confirmed it is not classified as a Large Corporate and has NIL qualified borrowings.
Strong earnings growth and steady dividend payout are positive signals for shareholders. The unchanged dividend despite a sharp jump in profits may lead to calls for higher payouts going forward, while the clean audit and zero-debt status reinforce financial stability.